This is unpublished

Frederick R.
Appelbaum
M.D.

he, him, his
Physician & Research Faculty
Pinned
Academic
Executive Vice President and Deputy Director, Fred Hutchinson Cancer Research Center
Professor, Clinical Research Division, Fred Hutch
Metcalfe Family/Frederick Appelbaum Endowed Chair in Cancer Research, Fred Hutch
Professor of Medicine, Division of Medical Oncology, University of Washington
Sites of Practice
Seattle Cancer Care Alliance

Photo: Robert Hood / Fred Hutch News Service 

Education, Training, Board Certifications

  • M.D., Tufts University
  • Residency, University of Michigan Medical Center
  • Clinical Associate, National Cancer Institute
  • Medical Oncology, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine

Clinical Expertise

  • Hematopoietic stem cell transplantation
  • Hematologic malignancies
  • Leukemia
  • Lymphoma

Affiliations

Publications  

 

Research and/or clinical interests

Dr. Fred Appelbaum studies the biology and treatment of leukemias, lymphomas and other blood cancers and sees patients with these disorders. He has made numerous landmark contributions to his field. Notably, he helped develop Fred Hutch’s renowned program in blood stem cell transplantation. He also participated in the Hutch’s pioneering work to develop targeted antibody-based cancer therapies. Today, Dr. Appelbaum leads Fred Hutch’s Adult Leukemia Research Center and the Hematologic Malignancy Program of the Fred Hutchinson/University of Washington Cancer Consortium. These efforts are aimed at enhancing our understanding of these diseases and improving treatments like blood stem cell transplantation. As Fred Hutch deputy director, Dr. Appelbaum leads the implementation of key scientific strategies and partnerships. He also helps to ensure that Fred Hutch advances are shared with the wider community.